Real World Study of Classic Infectious Disease

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

This study aimed to collect and analyze clinical specimens of patients with classic infectious diseases in the real world. To investigate the epidemiological distribution of classic infectious diseases (brucellosis, epidemic hemorrhagic fever, kala-azar) and treatment options suitable for China.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
View:

⁃ Brucellosis: Patients with any of the following confirmed the evidence.

• sample culture: Brucella;

• Specific antigen or antibody (IgG or IgM) positive. epidemic hemorrhagic fever:

⁃ 1 specific antibody positive 2 Hantavirus RNA positive kala-azar:

• latent infection: rK39 antibody positive

• patients with the following evidence of kala-azar diagnosis: 1) bone marrow, spleen puncture sample culture: Leishmania; 2) bone marrow, spleen puncture sample smear: Leishmania; 3) clinical symptoms, history of exposure or epidemiology, and positive screening test (rK39 positive)

Locations
Other Locations
China
Huashan Hospital of Fudan University
RECRUITING
Shanghai
Contact Information
Primary
JingWen Ai, Doctor
jingwenai1990@126.com
+86 13764990804
Backup
YiQi Yu
yyq19890619@126.com
+86 13601637563
Time Frame
Start Date: 2020-05-13
Estimated Completion Date: 2029-06-01
Participants
Target number of participants: 10000
Treatments
kala-azar group
epidemic hemorrhagic fever group
brucellosis group
Related Therapeutic Areas
Sponsors
Collaborators: The First Affiliated Hospital of Lanzhou Medical University, The Fifth Affiliated Hospital Xinjiang Medical University, Qianfoshan Hospital, First Affiliated Hospital of Fujian Medical University, The ninth Hospital of NanChang city, Zibo Central Hospital, Qilu Hospital of Shandong University, First Affiliated Hospital of Xinjiang Medical University, First Affiliated Hospital of Harbin Medical University, The First Hospital of Jilin University, Linyi People's Hospital, Nanyang Central Hospital, Fuzhou Municipal Infectious Diseases Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The Second Hospital of Shandong University, Yuncheng Central Hospital, Huzhou Central Hospital, The Affiliated Hospital of Xuzhou Medical University, First Affiliated Hospital Xi'an Jiaotong University, Infectious Hospital of Jining City, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital of Nanchang University, The Affiliated Hospital of Jining Medical University and Zaozhuang City, The Second Affiliated Hospital of Henan Medical University, Henan Provincial People's Hospital, LanZhou University, Luoyang Central Hospital, The First Affiliated Hospital of Anhui Medical University, The First Affiliated Hospital of Shanxi Medical University, West Hospital of the First Affiliated Hospital of Guangxi University, People's Hospital of Xinjiang Uygur Autonomous Region, Nantong University
Leads: Huashan Hospital

This content was sourced from clinicaltrials.gov